RFA-NS-23-007 - HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R41/R42 Clinical Trial Not Allowed) is used for the submission of applications to the following Notices of Special Interest (NOSIs)

Active NOSIs

Title Notice Number Organization Release
Date
Expiration
Date
Activity
Code(s)

Expired NOSIs

Title Notice Number Organization Release
Date
Expiration
Date
Activity
Code(s)
Notice of Change to correct ORIPs listing under Components of Participating Organizations for PA-23-080, PA-23-230, PA-23-232, PAR-23-138, RFA-NS-23-006, and RFA-NS-23-007 NOT-OD-23-172 ORIP Sep 6, 2023 n/a R41/R42, R43/R44, S10, T35
Notice of NHLBI Specific Interests and Guidance in RFA-NS-23-007 "HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R41/R42 Clinical Trial Not Allowed) NOT-HL-22-051 NHLBI Sep 27, 2022 n/a R41/R42


Technical Issues: E-mail OER Webmaster